Navigation Links
Verenium Reports Financial Results for the Third Quarter 2010
Date:11/9/2010

tates and China;
  • Renewed and extended the Company's successful joint marketing agreement with Alfa Laval for Purifine® PLC for five years; and
  • Licensed a new lipase enzyme for use in the production of edible oil products to Bunge Oils, Inc.

  • Manufacturing

  • Hired Kevin Bracken as Vice President of Manufacturing to lead the optimization and expansion of manufacturing capabilities; and
  • Acquired control of additional fermentation capacity at Fermic, the Company's contract manufacturing facility in Mexico City.

  • Corporate/Financial:

  • Completed the sale of the Company's cellulosic biofuels business to BP, including facilities in Jennings, LA and San Diego, CA for net cash proceeds of $95.4 million;
  • Repurchased $21 million in principal amount of 8% and 5.5% Notes, eliminating all outstanding 8% Notes;
  • Appointed Alexander Fitzpatrick as Senior Vice President and General Counsel, further building out the senior management team;
  • Ended the quarter with unrestricted cash and cash equivalents totaling $89 million;
  • Increased total product revenue by 11% and 16% for the three and nine months ended September 30, 2010 respectively, when compared to the same periods in 2009;
  • Improved revenue mix from increasing sales of Company's newer enzymes including Fuelzyme, Xylathin, Veretase and Purifine; and
  • Increased product gross margin dollars by 17% and 20% for the three and nine months ended September 30, 2010 as compared to the same periods in 2009.

  • "The third quarter was an important quarter for Verenium in terms of demonstrating the growth potential of our enzyme products in all our industry areas," said James E. Levine, Executive Vice President and Chief Financial Officer.  "With the close of the BP transaction, we now have the financial flexibility to invest in the company and grow our enzymes business."

    Financial ResultsIn the commenta
    '/>"/>

    SOURCE Verenium Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related biology technology :

    1. Verenium to Present at Jefferies 10th Global Clean Technology Conference
    2. Verenium and Alfa Laval Announce Extension of Purifine® PLC Enzyme Agreement
    3. Verenium Announces Regulatory Approval for Purifine® PLC in China
    4. Verenium Launches DELTAZYM® GA L-E5 Enzyme for Fuel Ethanol Production
    5. Verenium Appoints Kevin Bracken Vice President of Manufacturing
    6. Verenium Announces Proposed Public Offering of Common Stock
    7. Verenium 1:12 Reverse Stock Split Takes Effect
    8. Verenium Announces Reverse Stock Split to Take Effect September 9
    9. BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol
    10. Verenium Completes Amendment to 8% Senior Convertible Notes
    11. Verenium Announces Organizational Changes
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) ... on the development of autologous cell therapies, today ... 30, 2015, corporate highlights, and near-term milestones.  The ... at www.sedar.com ,  www.edgar.com and ... expects to launch its RCS-01 treatment for aging ...
    (Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... ... opportunity for venture capital funds, investment firms and animal health companies to hear ... have raised $160 million. Several have also received licensing agreements or distribution contracts. ...
    (Date:8/27/2015)... , Aug. 27, 2015 /PRNewswire/ - Portage ... Exchange: PBT.U), and Biohaven Pharmaceutical Holding Company Limited ... a Phase I study of BHV-0223, a glutamate ... (IND) regarding BHV-0223 and recently obtained clearance from ... proceed with human testing. Portage holds 54% equity ...
    (Date:8/27/2015)... 2015 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") ... June 30, 2015. Biorem,s complete second quarter financial statements and MD&A ... HIGHLIGHTS: in ,000,s except earnings per shareThree-months ended , Six -months endedJune ... 2015 , 2014 Revenue , 4,709 ... Gross profit , 1,656 , 56 , ...
    Breaking Biology Technology:RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4BIOREM Reports $718,000 Net Earnings for the Second Quarter 2BIOREM Reports $718,000 Net Earnings for the Second Quarter 3
    ... , Anne , Grabner 1 , Christoph Sachse 1 , ... , 1 Cenix BioScience GmbH, 2 ... , Sets of siRNAs focused on a specific , ... greatly increase the pace of pathway analysis and functional , ...
    ... Ambion now offers a complete Gene Expression Profiling Service* ... data analysis to our Full Service offering, , ... offering includes , consultation with Ambion's team ... and comprehensive data analysis. Ambion's long history of providing innovative, , ...
    ... Assess GAPDH siRNA delivery in less time for a fraction of the , ... Analyze from one to 96 samples simultaneously , ... toxicity , Use with Silencer ... Kit for a complete transfection optimization , solution ...
    Cached Biology Technology:Assessing Gene Function with siRNA Libraries 2Assessing Gene Function with siRNA Libraries 3Assessing Gene Function with siRNA Libraries 4Assessing Gene Function with siRNA Libraries 5Assessing Gene Function with siRNA Libraries 6Assessing Gene Function with siRNA Libraries 7Ambion Offers Gene Expression Profiling Service 2Ambion Offers Gene Expression Profiling Service 3A New Way to Assess siRNA Delivery Efficiency 2A New Way to Assess siRNA Delivery Efficiency 3A New Way to Assess siRNA Delivery Efficiency 4A New Way to Assess siRNA Delivery Efficiency 5
    (Date:7/31/2015)... , 31 de julio de 2015 ... (ICG-10,  www.icg-10.org ) del 22 al 25 de octubre ... La conferencia celebra su décimo aniversario este ... convertido en una de las reuniones anuales más influyentes ... es una de las conferencias científicas más dinámicas, entusiastas ...
    (Date:7/31/2015)... SHENZHEN , Chine, 31 juillet 2015 /PRNewswire/ ... (ICG-10, www.icg-10.org ) sera organisée par le ... Shenzhen en Chine. ... année. Depuis son inauguration en 2006, l,ICG est ... influentes dans le domaine des « omiques » et c,est ...
    (Date:7/31/2015)... Die 10. internationale Konferenz zu Genomik ... und findet vom 22. bis 25. Oktober 2015 ... Die Konferenz feiert in diesem ... ist die ICG weltweit zu einem der einflussreichsten ... eines der dynamischsten, enthusiastischsten und angenehmsten wissenschaftlichen Zusammentreffen. ...
    Breaking Biology News(10 mins):La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3
    ... - FEBS Letters, one of the leading journals for ... new enhancement to the journal article: Structured Digital Abstracts ... Letters is an extension of the regular journal article ... which contains a relationship between two biological entities, mentioning ...
    ... 2, 2008) Autism Speaks, the nations largest autism ... Science and one of the countrys leading autism researchers ... will examine the architecture of the autistic brain. Led ... University of California, San Diego, School of Medicine and ...
    ... premier forum for health care executives to explore a ... leaders. The 2008 Congress will include senior executives and ... systems, health plans, pharmaceutical and biotech companies, and government. ... Health Care Agenda, will feature key health care advisors ...
    Cached Biology News:FEBS Letters Structured Digital Abstracts experiment 2Autism Speaks collaborates on grant with the Allen Institute for Brain Science and autism expert 2Autism Speaks collaborates on grant with the Allen Institute for Brain Science and autism expert 35th Annual World Health Care Congress April 21-23, Washington, D.C. 2
    ... The Aquarius 384 is a compact ... 384-well head is a unique flow-through ... using the included wash system. ... microplate stacker system. Will be ...
    ... 'SoftLinx software, a multitasking application capable ... the programming and operation of lab automation ... enough for custom modification by programmers. ... a simple drag-anddrop flowchart. If you can ...
    ... laboratory's requirements for data management and quality control. ... ... ... software for Staccato Systems and custom Allegro Modules allowing for the simple interface with more than ...
    ... is an integrated digital microscope and camera ... equipment setup, optical adjustment or software installation. ... technology, COOLSCOPE combines simplicity and advanced technology ... offers simultaneous viewing of a macro image ...
    Biology Products: